Last quarter (Q1 2025), Helix BioPharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Helix BioPharma's net income was $-1.34M. See Helix BioPharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jul 24	Jul 23	Jul 22	Jul 21	Jul 20
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 4.32M	$ 9.37M	$ 6.38M	$ 6.06M	$ 9.13M	$ 8.62M
Operating Income	$ -4.32M	$ -9.37M	$ -6.38M	$ -6.06M	$ -9.13M	$ -8.62M
Net Non Operating Interest Income Expense	$ 1.00K	$ 24.00K	$ 33.00K	$ -14.00K	$ 353.00K	$ ―
Other Income Expense	$ -274.00K	$ -132.00K	$ 3.00K	$ 501.00K	$ -90.00K	$ 55.00K
Pretax Income	$ -4.07M	$ -9.26M	$ -6.29M	$ -6.59M	$ -9.57M	$ -8.56M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -4.07M	$ -9.26M	$ -6.29M	$ -6.59M	$ -8.04M	$ -8.98M
Basic EPS	$ -0.09	$ -0.21	$ -0.03	$ -0.04	$ -0.06	$ -0.07
Diluted EPS	$ -0.09	$ -0.21	$ -0.03	$ -0.04	$ -0.06	$ -0.07
Basic Average Shares	$ 472.05M	$ 44.49M	$ 193.23M	$ 149.49M	$ 137.89M	$ 127.71M
Diluted Average Shares	$ 472.05M	$ 44.49M	$ 193.23M	$ 149.49M	$ 137.89M	$ 127.71M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 1.59M	$ 9.37M	$ ―	$ 6.06M	$ -9.13M	$ -8.62M
Net Income From Continuing And Discontinued Operation	$ -4.07M	$ -9.26M	$ -6.29M	$ -6.59M	$ -8.04M	$ -8.98M
Normalized Income	$ -4.30M	$ -9.17M	$ -4.63M	$ -4.84M	$ -7.04M	$ -6.29M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -4.04M	$ -9.26M	$ -6.28M	$ -6.57M	$ -9.56M	$ -8.54M
EBITDA	$ -4.03M	$ -9.26M	$ -6.26M	$ -6.56M	$ -9.36M	$ -8.32M

Currency in USD

Helix BioPharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing